All articles published by BioMedicine are dedicated to following the best practices on ethical matters, errors and restrictions. It is necessary to agree upon standards of expected ethical behavior for all parties involved: authors, editors, and reviewers.
Our ethic statements for our journal are based on the guidelines on the Committee on Publication Ethics (COPE) Best Practice Guidelines for Journal Editors. All authors, editors and reviewers within BioMedicine should adhere to the standards set out below.
Duties of Editors
The handling editor of BioMedicine is responsible for deciding which of the article to the journal should be published. The editor may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers in making this decision.
Submitted manuscripts are evaluated for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic, origin, citizenship, or political philosophy of the authors.
The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the explicit written consent of the author(s).
Duties of Reviewers
Contribution to editorial decisions
Peer review assists the editor in making editorial decisions and through the editorial communications with the author, may also assist the author in improving the paper.
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its timely review will be impossible should immediately notify the editor and excuse himself or herself from the review process so that alternative reviewers can be contacted.
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.
Standards of objectivity
Acknowledgement of sources
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
Disclosure and conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the submission.
The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be acknowledged within 1 week of submission, and authors will be provided with a manuscript reference number for future correspondence. If such an acknowledgment is not received in a reasonable period of time, the author should contact the Editorial Office. Submissions are reviewed by the Editorial Office to ensure that it contains all parts. The Editorial Office will not accept a submission if the author has not supplied all the material and documents as outlined in these author instructions.
Manuscripts are then forwarded to the Editor-in- Chief, who makes an initial assessment of it. If the manuscript does not appear to be of sufficient merit or is not appropriate for the Journal, then the manuscript will be rejected without review.
Manuscripts that appear meritorious and appropriate for the Journal are reviewed by at least two Editorial Board members or expert consultants assigned by the Editor-in-Chief. Authors will usually be notified within 6 weeks of whether the submitted article is accepted for publication, rejected, or subject to revision before acceptance. However, do note that delays are sometimes unavoidable.
The manuscripts have all identifying information maintained by the editors prior to the beginning of the review process. Then, all manuscripts submitted to the journal are submitted to two reviewers independent from the editorial committee of the journal. Thus this process is single blind as the authors do not know the identity of the peer reviewers.
Duties of Authors
Authors reporting results of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
Data access and retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data and should in any event be prepared to retain such data for a reasonable time after publication.
Originality and plagiarism
Authors should ensure that submitted work is original and has not been published elsewhere in any language, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted. Applicable copyright laws and conventions should be followed.
BioMedicine submitted work implies that it has not been published and / or is not submitted for publication anywhere else. Publication must be approved by all authors. For ethics in publishing consult COPE.
BioMedicine has adopted a rigorous examination of every submitted manuscript towards plagiarism or text recycling using Turnitin. This tool allows the Editor-in-Chief to quickly identify even partial use of already published content, which cannot be re-published in this journal for various reasons, such as copyright issues, autoplagiarism, plagiarism, etc. In case of doubt, and in order to avoid any forms of plagiarism or text recycling, authors are invited to visit relevant webpages of universities across the world dealing with this topic, or probably the websites of their own institutions. Please visit these few examples:
- Standford University
- University of Toronto
- Université du Québec
- Universität Bamberg
- Univesität Heidelberg
- Université de Paris Descartes
Copyright material (e.g. tables, figures or extensive quotations) should be reproduced only with appropriate permission and acknowledgement.
Multiple, redundant or concurrent publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable.
Acknowledgement of sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.
Authorship of a manuscript
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
Hazards and human or animal Subjects
If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
Disclosure and conflicts of Interest
All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal’s editor or publisher and cooperate with them to either retract the paper or to publish an appropriate erratum.
In cases of alleged or proven scientific misconduct, fraudulent publication or plagiarism the publisher, in close collaboration with the Editors-in-Chief, will take all appropriate measures to clarify the situation and to amend the article in question. This includes the prompt publication of an erratum or, in the most severe cases, the complete retraction of the affected work.
The Publisher and the Journal do not discrimination the basis of age, color, religion, creed, disability, marital status, veteran status, national origin, race, gender, genetic predisposition or carrier status, or sexual orientation in its publishing programs, services and activities.
The Publisher is committed to the availability of publications and ensures the content preservation/accessibility by partnering with the corresponding organizations. All BioMedicine content is archived in PubMed Central.
Statement of Informed Consent
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note, authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.
Statement of Human and Animal Rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.